Monitoring chemotherapeutic response in RIF-1 tumors by single-quantum and triple-quantum-filtered (23)Na MRI, (1)H diffusion-weighted MRI and PET imaging.
The effects of 5-fluorouracil (5FU, 150 mg/kg, ip) on subcutaneously implanted radiation-induced fibrosarcoma (RIF-1) tumors were monitored by in vivo (1)H MRI to evaluate the water apparent diffusion coefficient (ADC), by single-quantum (SQ) and triple-quantum-filtered (TQF) (23)Na MRI to evaluate compartmental Na(+) content and by positron emission tomography (PET) to evaluate 2-[(18)F]fluoro-2-deoxy-d-glucose (FDG) uptake in the tumor. The MRI experiments were performed on untreated control and treated mice once before and then daily for 3 days after treatment. The PET experiments were performed on separate groups of age- and tumor-volume-matched animals once before and then 3 days after treatment. Tumor volumes significantly decreased in treated animals 2 and 3 days posttreatment. At the same time points, in vivo MRI measurements showed an increase in both total tissue SQ (23)Na signal intensity (SI) and water ADC in treated tumors while control tumors showed no change in these parameters. TQF (23)Na SI and FDG uptake were significantly lower in treated tumors compared with control tumors 3 days after 5FU treatment. The correlated increases in total tissue (23)Na SI and water ADC following chemotherapy reflect an increase in extracellular space, while the lower TQF (23)Na SI and FDG uptake in treated tumors compared with control tumors suggest a shift in tumor metabolism from glycolysis to oxidation and/or a decrease in cell density.
Babsky
Andriy M
AM
Department of Radiology, Indiana University, Indianapolis, IN 46202-5181, USA. ababsky@iupui.edu
Zhang
Hong
H
Hekmatyar
Shahryar K
SK
Hutchins
Gary D
GD
Bansal
Navin
N
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D038524:Diffusion Magnetic Resonance Imaging; D016903:Drug Monitoring / Q000379:methods*; D005354:Fibrosarcoma / Q000000981:diagnostic imaging / Q000188:drug therapy*; D019788:Fluorodeoxyglucose F18; D005472:Fluorouracil / Q000494:pharmacology*; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008297:Male; D051379:Mice; D008809:Mice, Inbred C3H; D019275:Radiopharmaceuticals; D012964:Sodium / Q000737:chemistry; D013696:Temperature; D013997:Time Factors; D014055:Tomography, Emission-Computed; D016896:Treatment Outcome; D014407:Tumor Cells, Cultured; D014867:Water / Q000737:chemistry
D000970:Antineoplastic Agents; D019275:Radiopharmaceuticals; D014867:Water; D019788:Fluorodeoxyglucose F18; D012964:Sodium; D005472:Fluorouracil